The Enterprise Value as of December 2025 (TTM) for Lincoln Pharmaceuticals Limited (LINCOLN.NS) is 9.77B

According to Lincoln Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 9.77B. This represents a change of -23.61% compared to the average of 12.78B of the last 4 quarters.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Historical Enterprise Value (quarterly & annually)

How has LINCOLN.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Lincoln Pharmaceuticals Limited over the last ten years is 6.04B. The current 9.77B Enterprise Value has changed 16.08% with respect to the historical average. Over the past ten years (40 quarters), LINCOLN.NS's Enterprise Value was at its highest in in the December 2024 quarter at 15.78B. The Enterprise Value was at its lowest in in the March 2020 quarter at 2.51B.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lincoln Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Average Enterprise Value

How has LINCOLN.NS Enterprise Value performed in the past?

The current Enterprise Value of Lincoln Pharmaceuticals Limited (LINCOLN.NS) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Enterprise Value vs. Peers

How is LINCOLN.NS’s Enterprise Value compared to its peers?

Lincoln Pharmaceuticals Limited’s Enterprise Value is greater than Wanbury Limited (7.69B), greater than Wanbury Limited (7.69B), greater than Themis Medicare Limited (9.62B), greater than Themis Medicare Limited (9.62B), greater than Sakar Healthcare Limited (9.30B), less than Venus Remedies Limited (10.13B), less than Venus Remedies Limited (10.13B), less than Max India Limited (10.23B), greater than Ind-Swift Laboratories Limited (6.66B), greater than Ind-Swift Laboratories Limited (6.66B),

Build a custom stock screener for Lincoln Pharmaceuticals Limited (LINCOLN.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lincoln Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lincoln Pharmaceuticals Limited (LINCOLN.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lincoln Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.